Kratos’ 30% Revenue Surge Hides a Troubling Silence on Margins and Cash Flow

Continue Reading With a Free Account

Create a free account to see the full scanned list, new entries and chart analysis. No card needed.

Create Free AccountContinue With Google

Already registered? Sign in

Kratos Defense & Security Solutions reported a headline-grabbing second quarter: revenue of $458.8 million, up 30.5% year-over-year, and adjusted EPS of $0.21, beating analyst estimates by 51%. The stock rose 3.74% in after-hours trading. Management raised full-year guidance, touted a 1.3:1 book-to-bill ratio, and pointed to a record backlog of $2.08 billion. On the surface, this is a defense growth story firing on all cylinders.

1. the Lede and the Real Story

But beneath the optics, the real story is a widening gap between revenue growth and profitability. While revenue surged, the company’s adjusted EBITDA margin actually contracted from the prior quarter — from 15.4% in Q1 to 14.2% in Q2 — and operating cash flow turned negative at -$12.3 million, a stark reversal from the +$45.6 million generated in Q1. The CEO’s prepared remarks were cut off mid-sentence in the transcript, leaving analysts and investors without a full narrative on the company’s cash burn and margin trajectory. The real story is not the beat; it’s the quality of that beat and what management chose not to discuss.

Inside the Full Analysis

  • 🔒2. The Negative Space — What They Didn’t Say
  • 🔒3. Script vs. Reality
  • 🔒4. Evasion Tactics & The Hot Seat
  • 🔒5. Excuses vs. Execution
  • 🔒6. The CANSLIM Check
  • 🔒The Bottom Line

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading